Last Updated on eMC 25-05-2017 View medicine  | Merck Sharp & Dohme Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to other sources of information section

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - dose and frequency
  • Change to section 4 - possible side effects

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Improved presentation of PIL

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • New PIL for new product